Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Buyback
The lack of buybacks in December made me wonder if legal counsel advised against repurchases if PTSC knew there was a strong probability that a settlement was looming.  I knew several people here were hoping to see significant shares repurchased.  The only other reason to me for the lack of buybacks could be potential ongoing M&A negotations.
Share
New Message
Please login to post a reply